Skip to content

Randomized controlled clinical study on the rehabilitation of stroke patients with lL-27 related functional food combined with probiotics

Randomized controlled clinical study on the rehabilitation of stroke patients with lL-27 related functional food combined with probiotics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117104
Enrollment
Unknown
Registered
2026-01-20
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke hemiplegia

Interventions

intervention group:Conventional rehabilitation therapy and oral intake of functional food
Control:Conventional rehabilitation therapy and placebo

Sponsors

The First People's Hospital of Qinzhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Acute Phase Group 1. Patients with first-time stroke confirmed by CT/MRI 2. Onset 12 months 2. Persistent residual hemiplegia (Fugl-Meyer score < 80) 3. Age 40-75 years 4. Signed informed consent

Exclusion criteria

Exclusion criteria: 1.Hemiplegia not caused by stroke (trauma); 2.Combined severe heart, liver, and kidney failure; 3.Active malignant tumor or immune-related disease; 4.Chronic phase: Severe cognitive impairment, unable to cooperate with assessment (MMSE < 24); 5.Participated in other intervention studies within 30 days prior to enrollment; 6.Individuals with asthma, food or drug allergies;

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Rating;Diffusion weighted imaging indicators;Barthel Index;Magnetic Resonance Imaging indicators;Muscle strength assessment;

Secondary

MeasureTime frame
Adverse reaction record;breathe;heart rate;complete blood count;blood pressure;Four coagulation tests;Liver and kidney function;

Countries

China

Contacts

Public ContactYongguang Lu

The First People's Hospital of Qinzhou

503920577@qq.om+86 777 286 6871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026